Corrigendum to “Discovery of 3,4-dihydropyrimidine derivatives as novel Anti-PEDV agents targeting viral internalization through a unique calcium homeostasis disruption mechanism” [Europ. J. Med. Chem. 291 (2025) 117637]

IF 6 2区医学 Q1 CHEMISTRY, MEDICINAL

European Journal of Medicinal Chemistry Pub Date : 2025-04-30 DOI:10.1016/j.ejmech.2025.117683

Sai Lv , Rumeng Ma , Qun Tang , Xiaoyang Wang , Chunmei Wang , Keyu Zhang , Houkai Li , Wenchong Ye , Wen Zhou

引用次数: 0

查看原文本刊更多论文

“发现3,4-二氢嘧啶衍生物作为新型抗pedv药物，通过独特的钙稳态破坏机制靶向病毒内化”的勘误表[欧洲]。医学化学，291 (2025)117637]

作者感到遗憾的是<；图4是不完整的，作者希望更新图4来解决这个错误。更新后的图4已附在勘误表中。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

European Journal of Medicinal Chemistry 化学-医药化学

CiteScore

11.70

自引率

9.00%

发文量

863

审稿时长

29 days

期刊介绍： The European Journal of Medicinal Chemistry is a global journal that publishes studies on all aspects of medicinal chemistry. It provides a medium for publication of original papers and also welcomes critical review papers. A typical paper would report on the organic synthesis, characterization and pharmacological evaluation of compounds. Other topics of interest are drug design, QSAR, molecular modeling, drug-receptor interactions, molecular aspects of drug metabolism, prodrug synthesis and drug targeting. The journal expects manuscripts to present the rational for a study, provide insight into the design of compounds or understanding of mechanism, or clarify the targets.